Back to results
US 6,482,861 B2Granted
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
AssigneeThe University of Tennessee Research Corporation
InventorsDuane D. Miller, Leonid I. Kirkovsky, James T. Dalton, Arnab Mukherjee
Life of this patent
Estimating the term…
Abstract
The present invention relates to an antiandrogen compound and a method of treating prostate cancer in a patient utilizing the compound. The present invention also relates to a pharmaceutical composition which includes the compound.
Claims5
A method of irreversibly binding a compound to an androgen receptor of a mammal, comprising the step of contacting a compound of formula I to an
- androgen receptor of a mammal under conditions effective to irreversibly bind said compound to said androgen receptor;
- wherein
- Z is NCS or CN,
- R is NH2, NCS, N3 or NHCOCH2Y,
- X is S or SO2, and
- Y is a halogen, or
- wherein
- Z is NCS,
- R is F, and
- X is S or SO2.
7 more elements
Dependencies are inferred from the claim text.